← Leaderboards
Maria E Ryan
State University New York Stony Brook
$959,980
Attributed
$2,265,230
Total exposure
10
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $814.8K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,265,230 · 10
By mechanism
R44$1,507,000 · 1
R21$296,455 · 1
M01$251,775 · 7
R43$210,000 · 1
Top collaborators
- Glenn D Prestwich4 shared
- Justin Rodney Savage4 shared
- Won Yong Lee3 shared
- Ying Gu1 shared
- Thomas Preston Kennedy1 shared
- Narayanam Venkateswara Rao1 shared
Most similar at State University New York Stony Brook
Same institution · by research overlap
- Yingtian Pan$5,322,855
- Congwu Du$4,883,601
- Leslie G. Hyman$13,673,511
- Ying Gu$883,914
- Clinton T Rubin$6,381,589
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationPeriodontitisTooth LossSmokingDiabetes MellitusGingivitisPeriodontal DiseasesAlveolar BoneGlycosaminoglycansHuman SubjectAdvanced Glycosylation End ProductsDiabeticAnti-InflammatoryAnti-Inflammatory AgentsFibroblastsDrug FormulationsGingivaAmericanDoseCardiovascular DiseasesEthersChronicBaseBone Resorption
Grant awards (15)
Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis$7,000
R44 · FY2015 · DE
Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis$685,157
R44 · FY2014 · DE
Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis$814,843
R44 · FY2013 · DE
Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis$210,000
R43 · FY2011 · DE
HOST MODULATION/PERIODONTAL THERAPY EFFECTS ON DIABETES$2,377
M01 · FY2007 · RR · contact PI
A PLACEBO CONTROLLED, DOUBLE-BLIND STUDY OF CHEMICALLY MODIFIED TETRACYCLINE$50,465
M01 · FY2006 · RR · contact PI
HOST MODULATION/PERIODONTAL THERAPY EFFECTS ON DIABETES$12,712
M01 · FY2006 · RR · contact PI
EFFECTS OF TETRACYCLINES ON ACUTE PHASE PROTEINS IN SMOKERS W PERIODONTITIS$6,934
M01 · FY2006 · RR · contact PI
A PLACEBO CONTROLLED, DOUBLE-BLIND STUDY OF CHEMICALLY MODIFIED TETRACYCLINE$49,736
M01 · FY2005 · RR
EFFECTS OF TETRACYCLINES ON ACUTE PHASE PROTEINS IN SMOKERS W PERIODONTITIS$28,580
M01 · FY2005 · RR
HOST MODULATION/PERIODONTAL THERAPY EFFECTS ON DIABETES$21,899
M01 · FY2005 · RR
Effects of Tetracyclines on Acute Phase Proteins in Smokers w Periodontitis$45,184
M01 · FY2004 · RR
Host Modulation/Periodontal Therapy Effects on Diabetes$33,888
M01 · FY2004 · RR
Host Modulation/Periodontal Therapy Effects on Diabetes$150,500
R21 · FY2002 · DE
Host Modulation/Periodontal Therapy Effects on Diabetes$145,955
R21 · FY2001 · DE